← Open Payments lookup

JESSICA HOBAN: Open Payments

NPI 1710369392 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$599 in 17 payments from 10 companies in 2025. Trend: 2023 $704 · 2024 $172 · 2025 $599

Food & beverage: $500Education: $99
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP2$134
Janssen Biotech, Inc.1$99
Daiichi Sankyo Inc.3$88
TerSera Therapeutics LLC3$77
Merck Sharp & Dohme LLC2$45
Caris MPI, Inc.2$37
Takeda Pharmaceuticals U.S.A., Inc.1$36
Exelixis Inc.1$32
PFIZER INC.1$25
Syndax Pharmaceuticals, Inc.1$25

Products named: CALQUENCE, RYBREVANT, Enhertu, KEYTRUDA, Zoladex, MI CANCER SEEK, Xermelo, FRUZAQLA.

Industry payments across MD — which companies pay providers there.